IL17A and inflammatory bowel disease: The application of MSC in an animal model of IBD resulted in a significant decrease in IL-17 expression, a decrease in IL-17/IFN-γ-producing cells in the spleen, and a decrease in the accumulation of neutrophils in the intestine [129].